Catalyst Wire Dossier Catalyst Wire Dossier

Hyperimmune equine anti-SARS-CoV-2 serum (two formulations)

· Caja Costarricense de Seguro Social
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hyperimmune equine anti-SARS-CoV-2 serum (two formulations), covering 2021-03-19 to 2021-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients [Phase 2]

See pricing